Navigation Links
Total Artificial Heart Manufacturer SynCardia Secures $19M Financing
Date:3/20/2013

Artificial Heart to be used for destination therapy and pediatric bridge to transplant. The next step is for SynCardia to submit a Humanitarian Device Exemption application for each indication to the FDA for approval. Once approved, the HDEs will allow up to 4,000 U.S. patients annually to receive the 50cc Total Artificial Heart as destination therapy, and an additional 4,000 pediatric patients to receive the device as a bridge to transplant.

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 300 patient years of life.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

Forbes Ranks SynCardia #69 Among "America's Most Promising Companies"
In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth c
'/>"/>

SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Amedica Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
2. SynCardias 50cc Total Artificial Heart Receives Two HUD Designations from the FDA for Destination Therapy and Pediatric Bridge to Transplant
3. Ochsner Implants First Total Artificial Heart In The Gulf South Region
4. SynCardia Total Artificial Heart Patient with End-Stage Renal Failure Recovers Kidney Function after Two Months of Support
5. Total 3D Solutions Introduces Cinema ProMED System to Create Immersive Video Experiences for Dental Patients
6. University of Washington Leads All SynCardia Certified Centers with 10 Implants of the Total Artificial Heart in 2012
7. TriReme Announces a New Round of Financing Totalling US$18 Million
8. Computer-navigated total knee replacement provides no advantage over traditional surgical procedure
9. New Total Joint Replacement Registry From Remedy Informatics Aims to Enable Orthopedic Outcomes Research and Improve Quality for Hospitals and Orthopedic Surgery Groups
10. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
11. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Medical Alarm Concepts Holding, Inc. (OTC Bulletin Board: MDHI), manufacturer ... you to speak and listen directly through the pendant, announced today ... grocery stores. , , ... Under the terms of the distribution agreement signed in March of ...
... BEIJING , July 13 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. ... and sale of medical devices and homecare medical products in ... line,(QS-100A series) from Beijing Qiumanshi Technology Co., Ltd. The acquisition,includes the ... , , ...
Cached Medicine Technology:Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 2Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 2Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 3Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line 4
(Date:5/23/2013)... 2013 Applied PilotFish Healthcare Integration ... it has added support for the Direct Protocol to ... for Healthcare. In addition to the product’s already included ... and Web Services, it now offers support for the ... a specification of the Direct Project and ...
(Date:5/23/2013)... A new report estimates that ... could save $2.1 billion without reducing access or the ... that Florida and other state Medicaid programs could make ... rely on to curb wasteful pharmacy spending. , ... MedicaidPharmacySavings.com . , “The easiest way for Florida ...
(Date:5/23/2013)... of patients with high-risk neuroblastoma a common tumor that ... using tumor-killing cancer drugs. A study published by Cell ... & Biology reveals a new genomic approach to ... causing cancer cells to differentiate, or convert from immature ... method, the researchers identified a compound that causes neuroblastoma ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... by JD Media Surge, LLC. Targeting members of the ... services online and attract new patients, the consulting service ... Internet marketing strategies. , The medical Internet marketing agency ... struggling to get results online. As part of the ...
(Date:5/23/2013)... Traditionally, laser skin therapy has been used ... colour, this can be tricky. Based on the Fitzpatrick ... treated safely with most lasers. Darker skins, who are ... been left without recourse. Those who would most benefit ... successfully. , Hyperpigmentation occurs when there is ...
Breaking Medicine News(10 mins):Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 3
... you that already! Older adults are more ... shared or not shared information with, according to a new ... the kind of memory faux pas that can lead to ... doctor,s office. Ironically, after making these memory errors older adults ...
... HealthDay Reporter , MONDAY, Aug. 30 (HealthDay ... pain in patients with nerve pain stemming from injuries ... with chronic nerve pain were taught to take a ... pipe, three times a day, for five days. The ...
... Quebec, Australia and the United Kingdom by publicly ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo ... million Canadians (19% of the population) currently use ... recent years. A 2009 review of studies indicates ...
... 30 August 2010 - The notion that cutting or ... difficult to understand for most people, but it is ... themselves. Individuals with borderline personality disorder experience ... regulation skills. This group of people also displays high ...
... heart rhythm disorder is resulting in an alarming number ... A research team led by Professor Prash Sanders, ... Centre at the Royal Adelaide Hospital, found that hospital ... in Australia over a 15-year period. These findings ...
... Elsevier, a world-leading publisher of scientific, technical ... the launch of SciVerse, an innovative platform that ... scientific community to collaborate on the development of ... to releasing the APIs (application programming interfaces) for ...
Cached Medicine News:Health News:Older adults experience 'destination amnesia' 2Health News:Smoked Marijuana May Ease Chronic Nerve Pain 2Health News:Smoked Marijuana May Ease Chronic Nerve Pain 3Health News:Hurts so good -- neural clues to the calming effects of self-harm 2Health News:Heart disorder hits national epidemic proportions 2Health News:Elsevier introduces SciVerse, an innovative platform for accelerating science 2
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... On-Site Simplicity with Clinical Lab ... be used as an accurate ... or breath tests. In clinical ... by the Q.E.D.® demonstrated high ...
Medicine Products: